If you’ve been following gene therapy for sickle cell disease (SCD), you’ve probably heard about Casgevy (exa-cel)—a CRISPR-based gene-editing therapy currently approved for some patients ages 12+. In early December 2025, Vertex reported that children ages 5–11 in a study stayed free of painful vaso-occlusive crises for at least 12 months after treatment (in those with enough follow-up). Reuters
That’s a big deal, because many families are asking: Will these treatments ever be an option earlier in childhood? The data shared so far suggests researchers are actively pushing in that direction.
What gene therapy is (in plain language)
Gene therapies for SCD aim to address the disease at its source—your blood-forming stem cells. The process typically involves:
-
collecting a patient’s stem cells,
-
modifying them in a lab,
-
giving chemotherapy to make room in the bone marrow,
-
infusing the modified cells back.
For some people, the goal is long-term freedom from painful crises and complications. The tradeoff is that this is intensive, highly specialized care and not a quick outpatient treatment.
Important context: approvals and access
In the U.S., the FDA previously approved two gene therapies for sickle cell disease (Casgevy and Lyfgenia) for certain patients ages 12+ (criteria and risks vary). U.S. Food and Drug Administration
Outside the U.S., access decisions can differ—England’s NHS, for example, has moved forward on Casgevy with ongoing discussions about equitable access. BMJ
What Oklahoma families should ask their care team
If you’re curious whether gene therapy could ever be relevant for your child (now or later), here are practical questions:
-
Is my child’s sickle cell type and clinical history consistent with current eligibility pathways?
-
What are the short-term risks of the conditioning chemotherapy? (This is one of the biggest considerations.)
-
Where is the nearest treatment center that can evaluate us?
-
What does follow-up care look like (months and years)?
-
What costs are typically covered and what prior authorizations are required?
Our take
We’re encouraged by progress—especially as studies begin including younger children—but we also want families to have the full picture: this is a powerful option for some, and it’s also a major medical journey.
If you want help preparing questions for a clinic visit, our team can help you build a “visit checklist” so you walk in confident and organized.
Disclaimer: This article is educational and does not provide medical advice. Please consult your healthcare team.